Clozapine, agranulocytosis, and benign ethnic neutropenia

Postgraduate Medical Journal

Volumn 81, Issue 959, 2005, Pages 545-546

  Rajagopal, S ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HLA ANTIGEN;

AGE; AGRANULOCYTOSIS; ANEMIA; ARAB; ASIAN; BENIGN ETHNIC NEUTROPENIA; CAUCASIAN; DRUG MONITORING; EDITORIAL; EOSINOPHILIA; ETHNIC GROUP; HUMAN; IRELAND; JEW; LEUKOCYTE COUNT; LEUKOCYTOSIS; LYMPHOCYTOPENIA; NEGRO; NEUTROPENIA; RISK FACTOR; SCHIZOPHRENIA; SEX RATIO; THROMBOCYTOPENIA; UNITED KINGDOM;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; NEUTROPENIA; RISK FACTORS; SCHIZOPHRENIA;

EID: 24744435736     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2004.031161     Document Type: Editorial

References (14)

1. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988;45:789-96.
2. National Institute for Clinical Excellence. Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical guideline 1. London: NICE, 2002.
3. Alvir JM, Lieberman JA, Safferman AZ, et al. Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N Engl J Med 1993;329:162-7.
4. Atkin K, Kendall F, Gould D, et al. Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland. Br J Psychiatry 1996;169:483-8.
5. Gillman K. Paradoxical pattern of haematological risk with clozapine. Authors' reply. Br J Psychiatry 2000;177:88.
6. Munro J, O'Sullivan D, Andrews C, et al. Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. Br J Psychiatry 1999;175:576-80.
7. Alvir JM, Lieberman JA, Safferman AZ. Do white-cell count spikes predict agranulocytosis in clozapine recipients? Psychopharmacol Bull 1995;31:311-14.
8. Pirmohamed M, Park K. Mechanism of clozapine-induced agranulocytosis. Current status of research and implications for drug development. CNS Drugs 1997;7:139-58.
9. Claas FH. Drug-induced agranulocytosis: review of possible mechanisms, and prospects for clozapine studies. Psychopharmaclogy (Berl) 1989;99(suppl):S113-17.
10. Meged S, Stein D, Sitrota P, et al. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients. Int Clin Psychopharmacol 1999;14:305-12.
11. Banov MD, Tohen M, Friedberg J. High risk of eosinophilia in women treated with clozapine. J Clin Psychiatry 1993;54:466-9.
12. Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med 1999;133:15-22.
13. Shoenfeld Y, Alkan ML, Asaly A, et al. Benign familial leukopenia and neutropenia in different ethnic groups. Eur J Haematol 1988;41:273-7.
14. Kuno E, Rothbard AB. Racial disparities in antipsychotic prescription patterns for patients with schizophrenia. Am J Psychiatry 2002;159:567-72.